Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
life sciences
national
4
×
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
4
×
texas blog main
texas top stories
trial
4
×
wisconsin blog main
wisconsin top stories
clinical study
indiana blog main
indiana top stories
scott gottlieb
amgen
celgene
cholesterol
democrats
eli lilly
fda
gene editing
glaxosmithkline
grail
inclisiran
What
bio
cholesterol
roundup
abbvie’s
airport
annual
apocalypse
barbecuing
beds
big
bosley's
bosley’s
bridge
bucks
camping
cardiologist
cas
celgene
center
ceo
check
conference
crime
crispr
day
days
departure
drug
drugs
editas
exit
expensive
faces
fallout
financial
flop
foe
gone
guiding
healthcare
Language
unset
Current search:
national
×
" seattle top stories "
×
trial
×
@xconomy.com
4 years ago
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More
@xconomy.com
4 years ago
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.)
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More
@xconomy.com
5 years ago
Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout & More